Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

cantide

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Background Human xenograft models, resulting from orthotopic transplantation (implantation into the anatomically correct site) of… Expand
  • figure 1
  • table 1
  • figure 3
2011
2011
To study the pharmacokinetics of cantide, an antisense oligonucleotide, and its metabolites after iv gtt administration in rhesus… Expand
2005
2005
AbstractAim:To evaluate the in vivo antitumor effects of Cantide and the combined effect with 5-fluorouracil.Methods:An in situ… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 4
2005
2005
AIM To investigate the combination effect of hTERT antisense oligonucleotide "Cantide" and three chemotherapeutic drugs… Expand
2005
2005
Cantide is a 20-mer antisense phosphorothioate oligonucleotide that inhibits telomerase catalytic subunit hTERT, pharmacologic… Expand
2005
2005
AIM: To investigate the combination effect of hTERT antisense oligonucleotide "Cantide" and three chemotherapeutic drugs… Expand
2005
2005
Aim: To evaluate the in vivo antitumor effects of Cantide and the combined effect with 5-fluorouracil. Methods: An in situ human… Expand
2004
2004
Cantide is a 20-mer antisense phosphorothioate oligonucleotide that inhibits telomerase catalytic subunit hTERT. A capillary gel… Expand
Highly Cited
2003
Highly Cited
2003
Integrin activation generates different signalings in a cell type-dependent manner and stimulates cell proliferation through the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 6
  • figure 5
2003
2003
AIM To investigate the anti-tumor mechanism of antisense oligodeoxynucleotide cantide against hTERT. METHODS Tumor cells were… Expand